Literature DB >> 2475775

The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies.

D L Tolson1, S J Turco, R P Beecroft, T W Pearson.   

Abstract

Using intact Leishmania donovani promastigotes or purified L. donovani lipophosphoglycan (LPG) as immunogens, we have derived four LPG-specific monoclonal antibodies (MAbs). Two of these MAbs recognize an epitope consisting of the repeating phosphorylated galactose beta-1,4-mannose disaccharide portion of the molecule and cross-reacted with LPG from Leishmania major. These MAbs bound to the surface of living promastigotes of both species. The two other MAbs bound to the phosphosaccharide core structure of LPG and did not bind to the surface of living parasites, presumably due to masking of the core region. Experiments using all four MAbs with an LPG-deficient promastigote mutant indicated that both the repeat epitope and phosphosaccharide core were present in these cells, suggesting that incomplete assembly was responsible for the absence of intact LPG.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475775     DOI: 10.1016/0166-6851(89)90113-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  39 in total

1.  AuBr(3) mediated glycosidations: synthesis of tetrasaccharide motif of the Leishmania donovani lipophosphoglycan.

Authors:  Gopalsamy Sureshkumar; Srinivas Hotha
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

2.  MALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics.

Authors:  Morteza Razavi; Matthew E Pope; Martin V Soste; Brett A Eyford; Angela M Jackson; N Leigh Anderson; Terry W Pearson
Journal:  J Immunol Methods       Date:  2010-11-13       Impact factor: 2.303

Review 3.  The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes.

Authors:  M J McConville; M A Ferguson
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

4.  Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.

Authors:  E Handman
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

5.  Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan.

Authors:  P F Pimenta; E M Saraiva; E Rowton; G B Modi; L A Garraway; S M Beverley; S J Turco; D L Sacks
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.

Authors:  M Kelleher; A Bacic; E Handman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.

Authors:  D L Tolson; A Jardim; L F Schnur; C Stebeck; C Tuckey; R P Beecroft; H S Teh; R W Olafson; T W Pearson
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts.

Authors:  Upasna Gaur; Melissa Showalter; Suzanne Hickerson; Rahul Dalvi; Salvatore J Turco; Mary E Wilson; Stephen M Beverley
Journal:  Exp Parasitol       Date:  2009-03-27       Impact factor: 2.011

9.  Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18.

Authors:  Lee R Haines; Jamie M Thomas; Angela M Jackson; Brett A Eyford; Morteza Razavi; Cristalle N Watson; Brent Gowen; Robert E W Hancock; Terry W Pearson
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03

10.  The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V.

Authors:  Adrien F Vinet; Mitsunori Fukuda; Salvatore J Turco; Albert Descoteaux
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.